--- title: "ENvue Medical (FEED) news: reverse split" url: "https://aibio.space/companies/envue-medical/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "FEED reverse split news: ENvue Medical announces 1-for-12 reverse stock split effective September 1. ENvue Medical, Inc. (OTC: FEED), United States." --- FEED ENvue Medical, Inc. OTC · United States # ENvue Medical (FEED) news FEED reverse split news Listings · 2026-08-28 ## [ENvue Medical announces 1-for-12 reverse stock split effective September 1](https://aibio.space/news/envue-medical-announces-1-12-reverse-stock-split-effective-september-1/) Each 12 shares will combine into one, which would reduce the 11,084,616 common shares outstanding to about 923,718. The release says trading begins on the Nasdaq Capital Market on September 1, 2026, under the FEED symbol. ## Latest ENvue Medical news 1. 2026-08-12 Financings [ENvue Medical agrees to a $50 million committed equity facility](https://aibio.space/news/envue-medical-agrees-50-million-committed-equity-facility/) The company can sell up to $50.0 million of common stock to one institutional investor, and the same day it amended a Series H preferred stock agreement with that investor. ## ENvue Medical at a glance - **Ticker**: FEED - **Listing**: OTC - **Country**: United States - **Cash, Jun 30, 2026**: $1.1 million ### Related companies - [Green Planet Bio Engineering Co.](https://aibio.space/companies/green-planet-bio-engineering/) OTC: GPLB - [PACIFIC BIOSCIENCES OF CALIFORNIA, INC.](https://aibio.space/companies/pacific-biosciences-of-california/) NASDAQ: PACB - [QTREX Quantum](https://aibio.space/companies/qtrex-quantum/) NASDAQ: QTEX - [Quantum Cyber](https://aibio.space/companies/quantum-cyber-n-v/) NASDAQ: QUCY - [Beta Bionics](https://aibio.space/companies/beta-bionics/) NASDAQ: BBNX - [Hongchang International Co.](https://aibio.space/companies/hongchang-international/) OTC: HCIL - [Leef Brands](https://aibio.space/companies/leef-brands/) OTC: LEEEF - [BIODESIX INC](https://aibio.space/companies/biodesix/) NASDAQ: BDSX ### Also on OTC - [Cannaisseur Group](https://aibio.space/companies/cannaisseur/) TCRG - [BIOFORCE NANOSCIENCES HOLDINGS, INC.](https://aibio.space/companies/bioforce-nanosciences/) BFNH - [NKGen Biotech](https://aibio.space/companies/nkgen-biotech/) NKGN - [SORRENTO THERAPEUTICS INC](https://aibio.space/companies/sorrento-therapeutics/) SRNE - [Synergy CHC](https://aibio.space/companies/synergy-chc/) SNYRQ - [Syros Pharmaceuticals](https://aibio.space/companies/syros-pharmaceuticals/) SYRS ## ENvue Medical annual financials | Line | FY2025 | FY2024 | |---|---|---| | Research and development | [$1.8 million](https://www.sec.gov/Archives/edgar/data/1326706/000149315226016871/) | [$909,000](https://www.sec.gov/Archives/edgar/data/1326706/000149315226016871/) | | Net income (loss) | [-$18.2 million](https://www.sec.gov/Archives/edgar/data/1326706/000149315226016871/) | [-$3.7 million](https://www.sec.gov/Archives/edgar/data/1326706/000149315226016871/) | | Cash from operations | [-$9.4 million](https://www.sec.gov/Archives/edgar/data/1326706/000149315226016871/) | [-$2.5 million](https://www.sec.gov/Archives/edgar/data/1326706/000149315226016871/) | | Cash and equivalents | [$4.2 million](https://www.sec.gov/Archives/edgar/data/1326706/000149315226038778/) | [$752,000](https://www.sec.gov/Archives/edgar/data/1326706/000149315226016871/) | Latest balance sheet, Jun 30, 2026 (10-Q): cash and equivalents $1.1 million. Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice. ## Questions about ENvue Medical Did ENvue Medical do a reverse stock split? Our latest story on this, dated Aug 28, 2026: "ENvue Medical announces 1-for-12 reverse stock split effective September 1". The story links the filing or release it is based on. [Read the story](https://aibio.space/news/envue-medical-announces-1-12-reverse-stock-split-effective-september-1/). What is the ticker symbol of ENvue Medical? ENvue Medical, Inc. trades under the ticker FEED on OTC. Where is ENvue Medical listed? ENvue Medical, Inc. is listed on OTC. Which country or territory is ENvue Medical listed under? Our directory records ENvue Medical, Inc. under United States. Does aibio.space cover ENvue Medical? aibio.space lists ENvue Medical, Inc. among 2,820 public biotech companies and publishes its news here as stories appear. Is ENvue Medical profitable? ENvue Medical, Inc. reported a net loss of $18.2 million for the fiscal year ended Dec 31, 2025, and used $9.4 million of cash in operations, per its annual report to the SEC. How much does ENvue Medical spend on research and development? $1.8 million in the fiscal year ended Dec 31, 2025, per its annual report. How much cash does ENvue Medical have? $1.1 million in cash at Jun 30, 2026, per its 10-Q. What is the latest ENvue Medical (FEED) stock news? Our latest story on ENvue Medical, dated Aug 28, 2026: "ENvue Medical announces 1-for-12 reverse stock split effective September 1". Each 12 shares will combine into one, which would reduce the 11,084,616 common shares outstanding to about 923,718. The release says trading begins on the Nasdaq Capital Market on September 1, 2026, under the FEED symbol. [Source](https://aibio.space/news/envue-medical-announces-1-12-reverse-stock-split-effective-september-1/). What is ENvue Medical's latest stock offering or financing news? Our latest financing story, dated Aug 12, 2026: "ENvue Medical agrees to a $50 million committed equity facility". The company can sell up to $50.0 million of common stock to one institutional investor, and the same day it amended a Series H preferred stock agreement with that investor. [Source](https://aibio.space/news/envue-medical-agrees-50-million-committed-equity-facility/). How can I follow ENvue Medical (FEED) news? Press Follow on this page to add ENvue Medical to your Following list, or subscribe to the aibio.space newsletter. We have published 2 stories naming ENvue Medical so far, in Financings, Listings. ## Investor discussion: ENvue Medical Members talk about ENvue Medical (FEED). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at ENvue Medical, newest first. Each line links the filing it comes from. 1. 2026-08-31 Listings Reported a reverse stock split. SEC Form 8-K (Items 5.03,8.01,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1326706/000149315226040814/ex99-1.htm) 2. 2026-08-14 Listings Reported a shareholder vote on a reverse stock split or more authorized shares. SEC Form 8-K (Items 5.07). [Source](https://www.sec.gov/Archives/edgar/data/1326706/000149315226038305/form8-k.htm) 3. 2026-08-14 Distress Told the SEC a periodic report would be filed late. SEC Form NT 10-Q. [Source](https://www.sec.gov/Archives/edgar/data/1326706/000149315226038370/formnt10-q.htm) 4. 2026-07-24 Listings Asked shareholders to approve a reverse stock split. SEC Form DEF 14A. [Source](https://www.sec.gov/Archives/edgar/data/1326706/000149315226034623/formdef14a.htm) 5. 2026-07-14 Listings Asked shareholders to approve a reverse stock split. SEC Form PRE 14A. [Source](https://www.sec.gov/Archives/edgar/data/1326706/000149315226033204/formpre14a.htm) 6. 2026-07-10 Listings Reported a notice from its stock exchange about continued listing requirements. SEC Form 8-K (Items 3.01,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1326706/000149315226032830/form8-k.htm) 7. 2026-05-15 Distress Told the SEC a periodic report would be filed late. SEC Form NT 10-Q. [Source](https://www.sec.gov/Archives/edgar/data/1326706/000149315226023730/formnt10-q.htm) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open OTC:FEED on TradingView](https://www.tradingview.com/symbols/OTC-FEED/). ## Listing details ENvue Medical, Inc. is a public biotech or pharmaceutical company listed on OTC under the ticker FEED, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: ENvue Medical, Inc. - **Ticker**: FEED - **Listing**: OTC - **Country or territory**: United States Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/envue-medical/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "ENvue Medical (FEED) news: reverse split", 2026-10-31, https://aibio.space/companies/envue-medical/